Kanagawa, Japan

Eisaku Yoshihara

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tokai University. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eisaku Yoshihara. Retrieved from https://idiyas.com/inventor/eisaku-yoshihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eisaku Yoshihara: Innovator in Drug Efflux Pump Inhibition

Introduction

Eisaku Yoshihara is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of drug efflux pump inhibition. His innovative work aims to enhance the efficacy of drug treatments by targeting specific proteins involved in drug resistance.

Latest Patents

Yoshihara holds a patent that focuses on a method and agent designed to efficiently inhibit the function of the drug efflux pump. The invention outlines a method that involves modifying specific amino acid residues in the amino acid sequence of the mature OprM protein. This modification is crucial for developing agents that can effectively inhibit the drug efflux pump's function, thereby improving drug efficacy.

Career Highlights

Eisaku Yoshihara is affiliated with Tokai University, where he conducts research and develops innovative solutions in the pharmaceutical field. His work has garnered attention for its potential to address challenges related to drug resistance, which is a significant concern in modern medicine.

Collaborations

Yoshihara collaborates with Hidatoshi Inoko, contributing to advancements in their shared research interests. Their partnership exemplifies the collaborative spirit often found in academic and research institutions.

Conclusion

Eisaku Yoshihara's contributions to drug efflux pump inhibition represent a significant advancement in pharmaceutical research. His innovative methods and collaborative efforts continue to pave the way for improved drug therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…